Xconomy

From Alnylam and Tekmira Seek New Ways to Deliver RNAi Drugs Deep in the Body:

alnylamtekmira logo
alnylamtekmira logo

Alnylam and Tekmira are conducting research to find new ways to deliver RNA-interference drugs.

    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.